Q4 2020 Holdings
Filed 2021-02-16 | 65 holdings | $16.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-04-29) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $8.9M | 268,548 | 53.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.3M | 21,477 | 13.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.0M | 42,743 | 12.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.0M | 56,909 | 6.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $955.0K | 3,899 | 5.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $605.0K | 33,813 | 3.7% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $397.7K | 2,825,000 | 2.4% |
| Bioatla Inc(BCAB)A | COM | 09077B104 | $108.1K | 3,179,362 | 0.7% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $28.3K | 2,375,681 | 0.2% |
| Galecto Inc(GLTOUSD)A | COM | 36322Q107 | $18.9K | 1,512,648 | 0.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $11.0K | 1,597,279 | 0.1% |
| Invitae Corp(NVTA1EUR)A | COM | 46185L103 | $10.2K | 244,760 | 0.1% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $10.0K | 742,085 | 0.1% |
| Ionis Pharmaceuticals Inc | NOTE 0.125%12/1 | 462222AB6 | $8.7K | $8,500,000 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.6K | 558,117 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $7.8K | 390,847 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $7.4K | 74,189 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $7.3K | 236,589 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $7.0K | 213,807 | 0.0% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $6.9K | 303,998 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $6.2K | 199,867 | 0.0% |
| Dariohealth Corp(DRIOEUR) | COM NEW | 23725P209 | $5.7K | 401,606 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.5K | 206,844 | 0.0% |
| Lyra Therapeutics Inc(LYRA)A | COM | 55234L105 | $5.2K | 456,138 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $5.0K | 107,826 | 0.0% |
| Vesper Healthcare Acqstn COR | COM CL A | 92538T104 | $4.7K | 416,551 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $4.3K | 24,999 | 0.0% |
| Oaktree Acquisition Corp | SHS CL A | G67145105 | $4.1K | 281,565 | 0.0% |
| Surmodics Inc(SU6) | COM | 868873100 | $4.0K | 92,975 | 0.0% |
| Misonix Inc(MSON) | COM | 604871103 | $3.8K | 301,333 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.2K | 64,284 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.0K | 8,165 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $3.0K | 18,938 | 0.0% |
| Itamar MED LTD | SPONSORED ADS | 465437101 | $2.8K | 140,524 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $2.5K | 66,921 | 0.0% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $2.5K | $2,750,000 | 0.0% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $2.5K | 45,951 | 0.0% |
| Rafael Hldgs Inc(RFL) | COM CL B | 75062E106 | $2.4K | 104,737 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $2.3K | 28,406 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.3K | 19,013 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $2.3K | 185,719 | 0.0% |
| Oncorus Inc | COM | 68236R103 | $1.8K | 56,422 | 0.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $1.8K | 105,941 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.7K | 7,838 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $1.7K | 27,612 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.7K | 9,589 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.7K | 10,825 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.5K | 103,819 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $1.5K | 135,992 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $1.4K | 336,442 | 0.0% |